Methylene Blue 50mg/10ml – IV Treatment for Methemoglobinemia

Methylene Blue 50mg/10ml is a fast-acting intravenous solution used to treat methemoglobinemia—a rare condition impairing oxygen delivery in the bloodstream. This treatment restores the iron in hemoglobin to its functional state, enabling proper oxygen transport. Administered in clinical settings, it is essential for emergency reversal of methemoglobinemia symptoms such as cyanosis, fatigue, and shortness of breath. Manufactured by Zydus Pharmaceuticals, this solution is reliable and clinically approved.